Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
Clinical trial NCT00423085 · COMPLETED
Trial details
- NCT number
- NCT00423085
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2009-03-01
- Enrollment
- 859
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.